Detalhe da pesquisa
1.
Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group.
Pediatr Blood Cancer
; 69(6): e29644, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35253352
2.
A Case of Cyclic Neutropenia and Associated Amyloidosis.
J Pediatr Hematol Oncol
; 43(8): e1115-e1117, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224518
3.
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.
Lancet Oncol
; 21(8): 1110-1122, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702309
4.
Risk-based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group.
Cancer
; 125(15): 2602-2609, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31067356
5.
The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
Cancer
; 125(2): 290-297, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30351457
6.
Consensus and controversies regarding the treatment of rhabdomyosarcoma.
Pediatr Blood Cancer
; 65(2)2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28905489
7.
Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Cancer
; 123(12): 2368-2375, 2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28211936
8.
Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 64(9)2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28333415
9.
Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 64(12)2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28521080
10.
Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups.
Pediatr Blood Cancer
; 62(12): 2125-31, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26257045
11.
Maintenance chemotherapy in rhabdomyosarcoma: the new standard of care.
Lancet Oncol
; 20(11): 1476-1477, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562042
12.
Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.
Pediatr Blood Cancer
; 60(7): 1083-94, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23418018
13.
Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis.
Cancer Med
; 12(9): 10222-10229, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37016270
14.
The significance of margins in pediatric Non-Rhabdomyosarcoma soft tissue sarcomas: Consensus on surgical margin definition harmonization from the INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT).
Cancer Med
; 12(10): 11719-11730, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36744538
15.
The treatment approach to pediatric non-rhabdomyosarcoma soft tissue sarcomas: a critical review from the INternational Soft Tissue SaRcoma ConsorTium.
Eur J Cancer
; 169: 10-19, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35490564
16.
Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee.
Int J Cancer
; 128(5): 1232-9, 2011 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20473932
17.
Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children's Oncology Group.
Pediatr Blood Cancer
; 57(1): 76-83, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21298768
18.
Metabolic response as assessed by 18 F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Cancer Med
; 10(3): 857-866, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33340280
19.
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force.
J Clin Med
; 10(7)2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33915882
20.
Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.
Am J Pathol
; 174(2): 550-64, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19147825